Oxford Biomedica (LON:OXB) Shares Pass Above Two Hundred Day Moving Average of $248.69

Shares of Oxford Biomedica plc (LON:OXB) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 248.69 ($3.22) and traded as high as GBX 355 ($4.59). Oxford Biomedica shares last traded at GBX 348.50 ($4.51), with a volume of 131,145 shares.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada reaffirmed an “outperform” rating and set a GBX 740 ($9.57) target price on shares of Oxford Biomedica in a research report on Tuesday, May 21st.

Oxford Biomedica Price Performance

The stock has a market cap of £368 million, a P/E ratio of -225.77 and a beta of 0.94. The company has a current ratio of 3.19, a quick ratio of 1.67 and a debt-to-equity ratio of 143.20. The company’s fifty day simple moving average is GBX 325.82 and its 200-day simple moving average is GBX 249.84.

Oxford Biomedica Company Profile

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.